FDA chief at odds with Congress

11/30/2006 | Washington Post, The

Dr. Andrew von Eschenbach, acting head of the FDA, refuses to give Congress all the information it seeks about the controversial antibiotic Ketek. Von Eschenbach said disclosure of the information could hinder the FDA's ability to independently and objectively evaluate drug safety and other issues. His position puts him on a collision course with Sen. Charles Grassley, R-Iowa, who is blocking Eschenbach's confirmation to be permanent head of FDA.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA